Cadonilimab+regorafenib

DRUG2 trials

Sponsors

Sun Yat-sen University, Meng Chao Hepatobiliary Hospital of Fujian Medical University

Conditions

Advanced Hepatocellular CarcinomaHepatocellular Carcinoma

Phase 1

A Study of Cadonilimab Combined With Regorafenib in Patients With Advanced HCC

CompletedNCT05773105

Sun Yat-sen UniversityAdvanced Hepatocellular Carcinoma

Start: 2023-09-19End: 2026-03-30Updated: 2026-06-10

Phase 2

A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib

RecruitingNCT06280105

Meng Chao Hepatobiliary Hospital of Fujian Medical UniversityHepatocellular Carcinoma

Start: 2024-03-31End: 2027-03-31Target: 40Updated: 2025-05-15